Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 1,035 shares at $4.21 ($5K) on 2025-04-03, disclosed to the SEC on 2025-05-09.
Scheduled purchase ($5k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.24 | 45 | $191 | 4.1% |
| 2 | $4.39 | 45 | $198 | 4.3% |
| 3 | $4.21 | 45 | $189 | 4.1% |
| 4 | $4.23 | 45 | $190 | 4.1% |
| 5 | $4.19 | 45 | $189 | 4.1% |
| 6 | $4.14 | 45 |
| $186 |
| 4.0% |
| 7 | $4.09 | 45 | $184 | 4.0% |
| 8 | $4.01 | 45 | $180 | 3.9% |
| 9 | $4.02 | 45 | $181 | 3.9% |
| 10 | $4.03 | 55 | $222 | 4.8% |
| 11 | $4.14 | 55 | $228 | 4.9% |
| 12 | $4.23 | 55 | $233 | 5.0% |
| 13 | $4.61 | 55 | $254 | 5.5% |
| 14 | $4.79 | 55 | $263 | 5.7% |
| 15 | $4.74 | 55 | $261 | 5.6% |
| 16 | $5.01 | 55 | $276 | 5.9% |
| 17 | $5.12 | 55 | $282 | 6.1% |
| 18 | $4.94 | 55 | $272 | 5.9% |
| 19 | $4.91 | 45 | $221 | 4.8% |
| 20 | $4.93 | 45 | $222 | 4.8% |
| 21 | $4.79 | 45 | $216 | 4.7% |
| Total | $4.48 avg | 1,035 | $5K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-04-04 | $5K | — | Filing → |